Human Leukocyte Antigen (HLA) and Tumor Immunity: A Critical Link in Cancer Immunotherapy

This review underscores the pivotal role of HLA molecules in cancer immunology. A deeper understanding of HLA-tumor interactions offers promising avenues for the development of HLA-based immunotherapies, potentially improving clinical outcomes in cancer treatment.

Authors

Donath Damian

Institutions

Mbeya University of Science and Technology (TZ)

Publication Details

Journal: Immunity Inflammation and Disease
Published: 2026-02-01
DOI: https://doi.org/10.1002/iid3.70363
Primary Topic: Immunotherapy and Immune Responses
Type: article
Field-Weighted Citation Impact: 0.00

Funders

University of Dar es Salaam

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Human Leukocyte Antigen (HLA) and Tumor Immunity: A Critical Link in Cancer Immunotherapy

Donath Damian

Feb 1, 2026

Immunity Inflammation and Disease

Immunotherapy and Immune Responses

article

Human Leukocyte Antigen (HLA) and Tumor Immunity: A Critical Link in Cancer Immunotherapy

Donath Damian

February 1, 2026article en

Abstract

Immunity Inflammation and DiseaseVol. 14(2)

Mbeya University of Science and Technology (TZ)

University of Dar es Salaam

Openalex Percentile: Top 52%

Immunotherapy and Immune Responses

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Human Leukocyte Antigen (HLA) and Tumor Immunity: A Critical Link in Cancer Immunotherapy — Donath Damian · Immunity Inflammation and Disease (2026) | TGRS Research Map | TGRS